Cost-effectiveness of pegfilgrastim versus filgrastim for prevention of chemotherapy-induced febrile neutropenia in patients with lymphoma: a systematic review

Girma Tekle Gebremariam, Atalay Mulu Fentie, Kebede Beyene, Beate Sander, Gebremedhin Beedemariam Gebretekle

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number1600
JournalBMC Health Services Research
Volume22
Issue number1
DOIs
StatePublished - Dec 2022
Externally publishedYes

ASJC Scopus Subject Areas

  • Health Policy

Keywords

  • Cost-effectiveness
  • Febrile neutropenia
  • Filgrastim
  • Lymphoma
  • Pegfilgrastim
  • Prophylaxis

Cite this